WASHINGTON—Patients treated for hepatitis C virus (HCV) by a specialty pharmacy between 2013 and 2017 achieved sustained virologic response (SVR) rates of 93.9%, according to an abstract presented by clinicians from OptiMed Specialty Pharmacy at the National Association of Specialty Pharmacy 2017 annual meeting.
“This suggests that real-world treatment of HCV with the latest direct-acting antiviral drugs, along with patient management by a specialty pharmacy, can yield similar SVR